IGFBP3 and diabetes mellitus: IGFBP3/TMEM219 blockade with ecto-TMEM219 prevented the onset of diabetes in nearly 75% of treated mice (up to 80%), while only 25% of control mice were protected from diabetes in the untreated group (Fig. 5e).